Xavier Electromyographic Wheelchair Control for Limited Mobility Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

4 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-11

Study Completion Date

2019-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the functional mobility and self-reported satisfaction with the Xavier electromyography hands-free wheelchair control system in comparison with a standard joystick.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Vision-Guided Shared Control for Assistive Robotics Manipulators

NCT04323449

Spinal Cord Injury/Disorder

COMPLETED NA

A Wheelchair Propulsion Training Program

NCT04009187

Spinal Cord Injuries Multiple Sclerosis Amputation +1 more

COMPLETED NA

Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving

NCT04072536

Neurological Disorders

COMPLETED NA

A P300 Brain Computer Interface to Operate Power Wheelchair Tilt

NCT01123148

Healthy Amyotrophic Lateral Sclerosis

COMPLETED NA

Real-time Neuromuscular Control of Exoskeletons

NCT04661891

Stroke

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amyotrophic Lateral Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Xavier wheelchair controller

Surface electromyography control of wheelchair

Group Type EXPERIMENTAL

Xavier wheelchair controller

Intervention Type DEVICE

Controlling a wheelchair using the Xavier surface EMG system

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Xavier wheelchair controller

Controlling a wheelchair using the Xavier surface EMG system

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ALS diagnosis by revised el Escorial criteria (definite, probable or probable laboratory supported)
* Age 18-89
* Limited mobility with use of motorized wheelchair at screening-time
* Impairment of hand function limiting the use of a standard joystick control
* Caregiver willing to assist with transfers into wheelchair and application of controllers
* Ability to attend study visits with a motorized wheelchair
* Ability to communicate and answer patient reported outcome measure questions

Exclusion Criteria

* Cognitive impairment prohibiting safe independent mobility as defined by an ALS-Cognitive Behavioral Screen (ALS-CBS) score of \<10 or the opinion of the investigator
* A sensory impairment prohibiting safe independent mobility in the opinion of the investigator
* Allergy to adhesives or electrode gels (required for EMG electrodes)
* Skin breakdown over the temporalis muscle that would predispose to further breakdown and/or infection with electrodes
* Severe loss of facial muscle functionality or control that would preclude EMG electrode efficacy
* Subjects who do not have the capacity to consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No